US Oncology(USON) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
US Oncology(USON)

An SI Board Since September 1999

Posts	SubjectMarks	Bans
75	4	0

Emcee: Arthur Radley	Type: Unmoderated

Introduction Compact

With the recent merger with Physcian's Reliance, the former American Oncology(AORI) has changed its name to US Oncology(USON). This merger has IMO enhanced USON's growth prospects, as now approximately 1/3rd of all cancer patients in this country will receive medical treatment through USON doctors. USON is truly a growth company in what is regrettably a growing market. By limiting their management practice strictly to the oncology field, USON has avoided the problems encountered by many of the physician management firms. This success model is confirmed by the consistent revenue growth and profits achieved in the history of the company.

Let's talk about USON!

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
75	USON has had a nice run and IMO more is ahead....http://www.twst.com/ceos/uson.h	Arthur Radley	-	2/10/2001
74	Tuesday October 10, 7:31 am Eastern Time Press Release SOURCE: US Oncology, Inc.	Ram Seetharaman	-	10/10/2000
73	USON is back! Monday September 18, 7:41 am Eastern Time Press Release SOURCE: U	Ram Seetharaman	-	9/18/2000
72	Ram: Unexciting quarter. EBITDA margins decline sequentially; decent revenue gr	Charlie Smith	-	8/15/2000
71	USON delivers! biz.yahoo.com	Ram Seetharaman	-	8/14/2000
70	This is one of those plays where you know you'll make money, especially get	Mancino	-	6/21/2000
69	Solid day for USON! Up to $ 4 1/2, on 5+ million volume! biz.yahoo.com US Ban	Ram Seetharaman	-	5/16/2000
68	Someone is buying today for sure! Just saw a 50000 chunk go through!	Ram Seetharaman	-	5/16/2000
67	Problem is that earnings on operations are down, the gain was from stock invest	Arthur Radley	-	5/15/2000
66	Solid prfits at USON - 29c! Stock is way undervalued! biz.yahoo.com	Ram Seetharaman	-	5/15/2000
65	I think this is a case of the VP leaving the company, therefore, one might expe	Arthur Radley	-	4/22/2000
64	You mentioned you think the street might know something. I'm more concerne	drstox	-	4/22/2000
63		Charlie Smith	-	4/17/2000
62	Actually a hell of a way to avoid losing, which appears to be a fairly common p	Charlie Smith	-	4/17/2000
61	well thats a great reason to buy into a company...lol...goodluck.	mact	-	4/17/2000
60	<i>im just giving another view</i> View from here is 2.5X EBITDA,	Charlie Smith	-	4/17/2000
59	just on a whim, i have gone back and read all of the posts on this thread...thi	mact	-	4/16/2000
58	It's mixed news, as I see it. The bad news is that it will take one if not	drstox	-	3/30/2000
57	USON is still quite cheap. I just saw 100000 chunk go through at $ 5 1/64! Some	Ram Seetharaman	-	3/23/2000
56	Earnings are out! Wednesday March 22, 5:21 pm Eastern Time Alert: Us Oncology	Ram Seetharaman	-	3/22/2000
55	... financial news is worse than expected? I have been watching this stock rece	Dave Chapman	-	2/25/2000
54	The $20 figure is based on two considerations: As soon as cash flow can be reas	drstox	-	2/24/2000
53	Well, I must agree, $20 would be great. But where did you get that number? An	Geriq	-	2/14/2000
52	I will be all the happier at USON - $ 20. USON got whacked too much, when it hi	Ram Seetharaman	-	1/12/2000
51	A double is a worst-case scenario. Congress will lighten up on Medicare this ye	drstox	-	1/12/2000

Go to reply# or date (mm/dd/yy):